Skip to main content
. 2023 Nov 21;13(11):e076715. doi: 10.1136/bmjopen-2023-076715

Figure 3.

Figure 3

Smoking history influences PFS in patients with non-small cell lung cancer who were prescribed pembrolizumab. Log-rank analysis, represented as Kaplan-Meier survival plots, was used to compare progression-free survival in (A) smokers (former and current; red) and non-smokers (blue) and in (B) current smokers (red), former smokers (green) and non-smokers (blue). Adapted from Mander et al.